Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Ho Han

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Digestive Diseases and Sciences|May 27, 2010
Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapySeong Hyun Jeong, Jae Ho Han, Jang Hee Kim, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?Seok Yun Kang, Mi Sun Ahn, Ga Won Song, et al.
Neuro-Oncology Advances|February 10, 2026
Plasma extracellular vesicle sampling from glioblastoma demonstrates a small RNA signature indicative of disease and identifies lncRNA <i>RPPH1</i> as a biomarkerJae Ho Han, Gabriel Wajnberg, Kathleen M Attwood, et al.
The American Journal of Surgical Pathology|November 5, 2021
Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell LymphomaJin Roh, Dok Hyun Yoon, Yoon Kyoung Lee, et al.
International Journal of Cancer|March 23, 2011
Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resectionSeok Yun Kang, Jae Ho Han, Mi Sun Ahn, et al.
Biochemical and Biophysical Research Communications|June 25, 2023
The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphomaJin Roh, Hyo-Kyung Pak, Seongfeel Jeong, et al.
Japanese Journal of Clinical Oncology|September 6, 2008
Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histologySeong Hyun Jeong, Hyun-Woo Lee, Jae Ho Han, et al.
Blood Advances|September 17, 2021
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutationsJiwon Koh, Insoon Jang, Seungchan Mun, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2009
Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapySeong Hyun Jeong, Jae Ho Jung, Jae Ho Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapySeok Yun Kang, Jae Ho Han, Kwang Jae Lee, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Digestive Diseases and Sciences|May 27, 2010
Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapySeong Hyun Jeong, Jae Ho Han, Jang Hee Kim, et al.
Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?Seok Yun Kang, Mi Sun Ahn, Ga Won Song, et al.
Neuro-Oncology Advances|February 10, 2026
Plasma extracellular vesicle sampling from glioblastoma demonstrates a small RNA signature indicative of disease and identifies lncRNA <i>RPPH1</i> as a biomarkerJae Ho Han, Gabriel Wajnberg, Kathleen M Attwood, et al.
The American Journal of Surgical Pathology|November 5, 2021
Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell LymphomaJin Roh, Dok Hyun Yoon, Yoon Kyoung Lee, et al.
International Journal of Cancer|March 23, 2011
Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resectionSeok Yun Kang, Jae Ho Han, Mi Sun Ahn, et al.
Biochemical and Biophysical Research Communications|June 25, 2023
The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphomaJin Roh, Hyo-Kyung Pak, Seongfeel Jeong, et al.
Japanese Journal of Clinical Oncology|September 6, 2008
Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histologySeong Hyun Jeong, Hyun-Woo Lee, Jae Ho Han, et al.
Blood Advances|September 17, 2021
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutationsJiwon Koh, Insoon Jang, Seungchan Mun, et al.
Lung Cancer (Amsterdam, Netherlands)|June 30, 2009
Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapySeong Hyun Jeong, Jae Ho Jung, Jae Ho Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapySeok Yun Kang, Jae Ho Han, Kwang Jae Lee, et al.
Pageof 16